|Videos|April 11, 2023
Efficacy and Safety of COVID-19 Vaccines in Children
Sean O’Leary, MD, discusses the importance of protection against severe disease vs infection of COVID-19, as well as safety considerations of COVID-19 vaccines in the pediatric population.
Advertisement
Episodes in this series
Advertisement
Related to this article
Completing the DTaP primary series was 96.2% effective against pertussis in Alaska children aged 6 months to 6 years during a record 2024 outbreak.
Todd Wolynn, MD, MMM, FAAP, explains how pediatricians can address misinformation through empathetic communication and community engagement.
A clinician-reported misinformation tracker at Children's Hospital of Philadelphia found vaccines accounted for 53.8% of 234 entries and informed education on 28 topics.
Sean T. O'Leary, MD, MPH, outlines 2026-2027 AAP influenza, COVID-19, and RSV guidance.
Jonathan Miller, MD, discusses earlier HPV vaccination, individualized conversations with hesitant families, and strategies to improve vaccine uptake.
Jonathan Miller, MD, discusses factors behind lagging HPV vaccination rates and how pediatricians can address common parent concerns.
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
Testosterone changes linked to emotional distress in pubertal girls
2
Tezepelumab sustains EoE remission through 52 weeks
3
Recognizing skin conditions in children with darker skin tones
4
FAQ: How should pediatricians manage UTIs under new AAP guidance?
5